Statement by the Board of Directors of Haldex in relation

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Sep 19, 2016 at 1:45 AM

Statement by the Board of Directors of Haldex in relation to the increased public cash offer by Knorr-Bremse

The Board of Directors of Haldex unanimously recommends the shareholders of Haldex not to accept the increased offer made by Knorr-Bremse. BACKGROUND This statement (the “Statement”) is made by the Board of Directors (the “Board”) of Haldex Aktiebolag (“Haldex” or the “Company”) pursuant to Section II.19 of Nasdaq Stockholm’s Takeover Rules (the “Takeover Rules”). On 16 September 2016, Knorr-Bremse AG (“Knorr-Bremse”) announced an increase of the consideration under its public cash offer to Haldex’s shareholders, to transfer their shares in Haldex to Knorr-Bremse, to SEK 125.00 per Haldex share. For more information about Knorr-Bremse’s increased offer, please refer to Knorr -Bremse’s announcement of its increased offer, available at www.Knorr -BremseandHaldex.com. On 16 September 2016, ZF Friedrichshafen AG, through its wholly-owned subsidiary ZF International B.V. (“ZF”), also announced an increase of its public cash offer to Haldex’s shareholders to SEK 120.00 per Haldex share. For more information about the increased offer by ZF, please refer to ZF’s announcement of its increased offer, which is available at www.zf.com. The Chairman of Haldex, Göran Carlson, has sold his shares in Haldex, representing approximately 5.7% of the total number of shares and votes in Haldex, to ZF. Please refer to ZF’s offer announcement of 14 September 2016 for more information about this agreement. As a result of Göran Carlson having sold his shares in Haldex to ZF, Göran Carlson has not participated in the Board’s decision regarding the Statement. The Board has appointed Magnus Johansson as acting chairman for the purpose of handling the Board’s decisions in relation to the ongoing offers for Haldex. Haldex has retained Lazard as financial adviser and Mannheimer Swartling as legal adviser. THE BOARD’S EVALUATION OF THE INCREASED OFFER The Board has unanimously decided to recommend the Haldex shareholders to accept the increased offer by ZF of SEK 120.00 per Haldex share, having concluded that there is a very real and material risk that Knorr-Bremse’s offer would fail to complete after a lengthy and disruptive review process and that Knorr-Bremse has done nothing to eliminate or reduce this risk, which under Knorr-Bremse’s offer would ultimately be borne by the Haldex shareholders. For more information about the reasons for the Board’s recommendation of ZF’s offer, please refer to the Board’s statement in relation to ZF’s increased offer that was announced earlier today through a separate press release, which is available at http://corporate.haldex.com. For information about the Board’s opinion of the effects the implementation of Knorr-Bremse’s offer may have on Haldex, specifically employment, and its views on Knorr-Bremse’s strategic plans for Haldex and the effect these may be expected to have on employment and the places where Haldex conducts its business, please refer to the Board’s statement in relation to Knorr-Bremse’s offer of 5 September 2016, which is available at http://corporate.haldex.com. On this basis, the Board unanimously recommends the Haldex shareholders not to accept the increased offer by Knorr-Bremse. ___________ The Statement shall in all respects be governed by and construed in accordance with substantive Swedish law. Disputes arising from the Statement shall be settled exclusively by Swedish courts. ___________ Landskrona, 19 september 2016 Haldex Aktiebolag (publ) The Board of Directors For further information, visit http://corporate.haldex.com or contact: Magnus Johansson, Board member and acting chairman Phone: +46 706 671812 Catharina Paulcén, SVP Corporate Communications Phone: +46 418 476157 E-mail: catharina.paulcen@haldex.com Haldex AB (publ) is required to publish the above information under the EU Market Abuse Regulation and the Takeover Rules. The information was submitted for publication by the Haldex media contact stated in the release on Sept 19, 2016 at 7.30 CEST. About Haldex With more than 100 years of intensely focused innovation, Haldex holds unrivaled expertise in brake systems and air suspension systems for heavy trucks, trailers and buses. We live and breathe our business delivering robust, technically superior solutions born from deep insight into our customers’ reality. By concentrating on our core competencies and following our strengths and passions, we combine both the operating speed and flexibility required by the market. Collaborative innovation is not only the essence of our products – it is also our philosophy. Our 2,100 employees, spread on four continents, are constantly challenging the conventional and strive to ensure that the products we deliver create unique value for our customers and all end-users. We are listed on the Nasdaq Stockholm Stock Exchange and have net sales of approximately 4.8 billion SEK.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stellus Capital Delivers Solid Q3 Amid Turbulent Times

Unpacking Stellus Capital's Latest Quarter Boy, Stellus Capital sure knows how to keep us on our toes. In a landscape where many are still reeling from the latest market tremors, they post some solid Q3 numbers for September 30, 2026. Not without its hiccups, but hey, who isn’t stumbling a bit right now? Financial Snapshot: Stability Amidst Uncertainty Stellus reported...

Zura Bio Faces Tough Road After Trial Failure

Investor Dilemma: ZURA Takes a Nosedive November 9, 2026, wasn't a day to remember for anyone holding shares in Zura Bio. If ever there's a classic lesson in biotech investing's volatility, this is it: shares of Zura Biotech (NASDAQ:ZURA) cratered by about 72% after news broke that their much-hyped Phase 2 TibuSHIELD trial for tibulizumab hit the skids. For a company that...

Houston's Health Museum Introduces 'Sensing Sound' Exhibit

Sound Takes Center Stage in Houston There's a new kind of hush in Houston and it ain't just the Texas sun setting low. Come November 21, The Health Museum throws its doors wide open with an exhibition that'll have visitors hearing sound like they've never imagined before. Now, I don't want to sound like a broken record, but this type of exhibition—the Sensing...

ALP's Bold NYC Pop-Up: A Gamble or Genius Move?

ALP Swings Big in the Big Apple Here's a move that's about as loud as blaring your TV at midnight — ALP, the nicotine pouch brand that’s been taking quiet corners of rural America by storm, is barging into New York City with a brazen pop-up and a parade of marketing antics. Think of it as taking the Wild West and plunking it down in the urban jungle. They're...

University of Phoenix Launches 3-Year IT Degree

Introducing the Three-Year IT Degree Pathway Listen up, folks—University of Phoenix is shakin' things up with a new three-year Bachelor's in Information Technology program. This isn't your average run-of-the-mill degree. It's a tailored pathway for IT pros who've been out there in the trenches for at least three years, getting their hands dirty with the tech. Why This...

Millrose Properties Faces Class Action Deadline Amid Turmoil

Millrose Properties: Legal Storm Brewing If you've got stock in Millrose Properties, Inc. (NYSE:MRP), you might want to listen up. There's a class action lawsuit in the works that could have quite the impact. Investors have until December 8, 2026, to throw their hat in the ring and maybe even lead the charge on this lawsuit. The Allegations Up Close Let's break down what...

Human Development Fund's Bold Partnership for Growth

An Unusual Alliance with Far-Reaching Implications Every once in a while, a nonprofit steps up with a move that makes even the toughest investors take notice. This isn't some Wall Street ticker talk, sure, but it’s worth turning your chair toward the table. The Human Development Fund (HDF) has penned a strategic deal with the Islamic Development Bank (IsDB), putting its...

Rosti Group Expands with Alvi Acquisition

By Ryan Hughes Updated Nov 9, 2026 Category News Views 166

Rosti Bets on Expansion with Alvi Buyout Rosti Group just rolled the dice big by swallowing Alvi Group, marking another bold move in the ever-swinging industrial and medical device manufacturing rodeo. Suddenly, we’re talking about a company with roughly 3,000 employees on its roster and a neat EUR 450 million in combined revenue. Don't overlook the power play...

Simtra Invests $250M in Major Expansion at Bloomington

Simtra BioPharma's Big Leap Forward Simtra BioPharma Solutions is making waves with their hefty $250 million investment, debuting their substantial expansion in Bloomington, Indiana. Building H isn't just another upgrade; it's a key piece in their ambitious strategy to bolster their sterile injectable manufacturing capacity. Lovers of big biotech moves, this one's worth...

Orthodontic Treatment: Timelines and Expert Insights

Getting Straight to the Point: Orthodontic Timelines Remember that time your teen self thought braces would be over in a flash? Yeah, well, Dr. Judith Okun might have a few words on that. When it comes to braces, you better buckle up for the long haul. Most folks are looking at a solid two years, give or take. No magic shortcuts here, just solid orthodontic science. The...